Eisenstein EL - Search Results

1

Obesity and long-term clinical and economic outcomes in coronary artery disease patients.

Eisenstein EL, Shaw LK, Nelson CL, Anstrom KJ, Hakim Z, Mark DB. Eisenstein EL, et al. Obes Res. 2002 Feb;10(2):83-91. doi: 10.1038/oby.2002.14. Obes Res. 2002. PMID: 11836453 Free article.

2

Importance of cost and quality of life in decisions about routine angiography after acute myocardial infarction. The role of cost-effectiveness models.

Eisenstein EL, Mark DB, Califf RM. Eisenstein EL, et al. Circulation. 1996 Sep 1;94(5):869-71. doi: 10.1161/01.cir.94.5.869. Circulation. 1996. PMID: 8790017 No abstract available.

3

Assessing the value of newer pharmacologic agents in non-ST elevation patients: a decision support system application.

Eisenstein EL, Peterson ED, Jollis JG, Tardiff BE, Califf RM, Knight JD, Mark DB. Eisenstein EL, et al. Proc AMIA Annu Fall Symp. 1997:273-7. Proc AMIA Annu Fall Symp. 1997. PMID: 9357631 Free PMC article.

4

Cost effectiveness of inpatient initiation of antiarrhythmic therapy for supraventricular tachycardias.

Simons GR, Eisenstein EL, Shaw LJ, Mark DB, Pritchett EL. Simons GR, et al. Among authors: eisenstein el. Am J Cardiol. 1997 Dec 15;80(12):1551-7. doi: 10.1016/s0002-9149(97)00773-x. Am J Cardiol. 1997. PMID: 9416934

5

A comparison of neural network models for the prediction of the cost of care for acute coronary syndrome patients.

Ismael MB, Eisenstein EL, Hammond WE. Ismael MB, et al. Among authors: eisenstein el. Proc AMIA Symp. 1998:533-7. Proc AMIA Symp. 1998. PMID: 9929276 Free PMC article.

6

Cost effectiveness of early discharge after uncomplicated acute myocardial infarction.

Newby LK, Eisenstein EL, Califf RM, Thompson TD, Nelson CL, Peterson ED, Armstrong PW, Van de Werf F, White HD, Topol EJ, Mark DB. Newby LK, et al. Among authors: eisenstein el. N Engl J Med. 2000 Mar 16;342(11):749-55. doi: 10.1056/NEJM200003163421101. N Engl J Med. 2000. PMID: 10717009 Free article.

7

Evaluating the potential 'economic attractiveness' of new therapies in patients with non-ST elevation acute coronary syndrome.

Eisenstein EL, Peterson ED, Jollis JG, Tardiff BE, Califf RM, Knight JD, Mark DB. Eisenstein EL, et al. Pharmacoeconomics. 2000 Mar;17(3):263-72. doi: 10.2165/00019053-200017030-00004. Pharmacoeconomics. 2000. PMID: 10947301

8

Assessing the clinical and economic burden of coronary artery disease: 1986-1998.

Eisenstein EL, Shaw LK, Anstrom KJ, Nelson CL, Hakim Z, Hasselblad V, Mark DB. Eisenstein EL, et al. Med Care. 2001 Aug;39(8):824-35. doi: 10.1097/00005650-200108000-00008. Med Care. 2001. PMID: 11468501

9

Advanced coronary artery disease: Appropriate end points for trials of novel therapies.

Kandzari DE, Lam LC, Eisenstein EL, Clapp-Channing N, Fine JT, Califf RM, Mark DB, Jollis JG. Kandzari DE, et al. Among authors: eisenstein el. Am Heart J. 2001 Nov;142(5):843-51. doi: 10.1067/mhj.2001.119136. Am Heart J. 2001. PMID: 11685173

10

Usefulness of psychosocial treatment of mental stress-induced myocardial ischemia in men.

Blumenthal JA, Babyak M, Wei J, O'Connor C, Waugh R, Eisenstein E, Mark D, Sherwood A, Woodley PS, Irwin RJ, Reed G. Blumenthal JA, et al. Am J Cardiol. 2002 Jan 15;89(2):164-8. doi: 10.1016/s0002-9149(01)02194-4. Am J Cardiol. 2002. PMID: 11792336 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

156 results

Search Page

Filters